GlassScriptPhysician profile
Marc J Thoma
NPI 1346747961
$7,849.73
in general payments reported to CMS, 2019-2025
8 companies · $2,962 in 2025
The $2,962 reported for 2025 was more than what 86% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $4,888 · 2025: $2,962.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,500 · Travel and Lodging: $1,699 · Food and Beverage: $650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,500.00 |
| Travel and Lodging | $1,699.44 |
| Food and Beverage | $650.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,629.26 | 2024-2025 | |
| Ethicon US, LLC | $56.22 | 2024 | Echelon; Endopath, Stratafix |
| Baxter Healthcare | $50.96 | 2024-2025 | Tisseel |
| Pacira Pharmaceuticals Incorporated | $34.16 | 2025 | Exparel, Iovera, Zilretta |
| Genzyme Corporation | $26.27 | 2024 | |
| Integra Lifesciences Corporation | $22.25 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Merck Sharp & Dohme LLC | $15.46 | 2025 | Bridion |
| Phathom Pharmaceuticals, INC. | $15.15 | 2024 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Thoma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.